Hospital Management
RSSArticles
-
Emergency Providers Identify Pulmonary Embolism in COVID-19 Patients
A new study highlights the critical role emergency providers play in identifying the incidence of pulmonary embolisms (PE) in patients who present with COVID-19. Researchers have delineated some factors that either heighten or decrease the risk that a patient has or may develop a PE so that treatment can be optimized at an early stage.
-
Chicago ED Accelerates Care, Improves Behavioral Health Prescribing Practices
The emergency department at St. Joseph Hospital in Chicago has implemented a two-pronged approach aimed at improving the way behavioral health patients are managed. This includes a new risk-stratification process that categorizes patients as low-, moderate-, or high-risk based on their diagnosis, and also promotes using newer-generation antipsychotic drugs.
-
Advocacy Groups Call for Removing Barriers to Mental Healthcare for Clinicians
Considering the unprecedented strain they face while working on the COVID-19 frontline, leading U.S. medical associations have outlined a series of steps intended to ensure all clinicians can access the self-care resources they need.
-
Address Patients’ COVID-19 Fears Through Thoughtful Design Changes, Clear Messaging
While some state hospital associations are leveraging their collective power to reassure patients that accessing needed care is important and safe, there are steps individual hospitals and emergency departments can take, too.
-
Clinical Leaders Urge Patients to Seek Care for Critical, Time-Sensitive Conditions
While COVID-19 continues surging in many regions, emergency departments across the country are confronting another significant problem: plummeting patient volumes. Many people with time-sensitive conditions such as stroke and heart attack are delaying or avoiding care, a reality that is leading to tragic results.
-
Biometrics Expert Discusses Data Integrity for COVID-19 Clinical Trials
The first remdesivir double-blind, placebo-controlled clinical trial for treating COVID-19 was published recently in Lancet. A member of the trial’s data safety monitoring board is Weichung Shih, PhD. Shih discussed the role of biostatisticians in protecting data integrity for clinical trials and the challenges during the COVID-19 pandemic.
-
Enhance Health Literacy Among Study Participants
IRBs can help improve health literacy among potential research participants using several tactics, including asking studies to use plain language in informed consent forms. IRBs can review informed consent and subject recruitment materials to ensure the study information is clear and adheres to regulatory requirements.
-
IRB Highlights Standardized and Effective Metrics Model
As IRBs and research programs increasingly seek IRBs of record and form reliance agreements, they will need to know whom to trust. IRBs also need their own performance data to share with sponsors, researchers, and others. The challenge is developing metrics that work and can be used by other IRBs for benchmarking purposes.
-
Court Rejects Challenge to Federal Price Transparency Rule
Plaintiffs announced intention to appeal decision.
-
Small IRB Copes with COVID-19 Pandemic Under Limited Budget
Many IRBs have seen clinical trial submissions decline since the COVID-19 pandemic began. Clinical trials also were put on hold. But work at Great Bay Community College — a one-person IRB office — has increased.